This document is an excerpt from the EUR-Lex website
Document 62013TO0044(01)
Order of the President of the General Court of 25 April 2013. # AbbVie, Inc. and AbbVie Ltd v European Medicines Agency (EMA). # Application for interim measures - Access to documents - Regulation (EC) No 1049/2001 - Documents held by the EMA containing information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market - Decision to grant a third party access to the documents - Application for suspension of operation of a measure - Urgency - Prima facie case -Weighing up of interests. # Case T-44/13 R.
Order of the President of the General Court of 25 April 2013.
AbbVie, Inc. and AbbVie Ltd v European Medicines Agency (EMA).
Application for interim measures - Access to documents - Regulation (EC) No 1049/2001 - Documents held by the EMA containing information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market - Decision to grant a third party access to the documents - Application for suspension of operation of a measure - Urgency - Prima facie case -Weighing up of interests.
Case T-44/13 R.
Order of the President of the General Court of 25 April 2013.
AbbVie, Inc. and AbbVie Ltd v European Medicines Agency (EMA).
Application for interim measures - Access to documents - Regulation (EC) No 1049/2001 - Documents held by the EMA containing information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market - Decision to grant a third party access to the documents - Application for suspension of operation of a measure - Urgency - Prima facie case -Weighing up of interests.
Case T-44/13 R.
European Court Reports 2013 -00000
ECLI identifier: ECLI:EU:T:2013:221